The effect of GLP-1 receptor agonists on cardiac remodeling in heart failure patients with preserved and reduced ejection fraction: a systematic review and meta-analysis
Around 10% of the 66 million Medicare beneficiaries are expected to be eligible for the drugs starting next year with new, expanded access
Enrolled participants were randomized to receive 3 mg, 7 mg, or 14 mg of oral semaglutide or placebo once daily for 52 weeks
As these treatments become increasingly popular, programs have been popping up around the country to offer these medications, but not all providers are the same
Alcohol, muscle loss, and nutrient status on GLP-1 Two considerations that get less attention
Ozempic and Wegovy contain the same active ingredient (semaglutide) but are FDA-approved for different uses